These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 31362745)

  • 1. Vasculogenic mimicry-associated ultrastructural findings in human and canine inflammatory breast cancer cell lines.
    Barreno L; Cáceres S; Alonso-Diez Á; Vicente-Montaña A; García ML; Clemente M; Illera JC; Peña L
    BMC Cancer; 2019 Jul; 19(1):750. PubMed ID: 31362745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histological, immunohistological, and ultrastructural description of vasculogenic mimicry in canine mammary cancer.
    Clemente M; Pérez-Alenza MD; Illera JC; Peña L
    Vet Pathol; 2010 Mar; 47(2):265-74. PubMed ID: 20106772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment and characterization of a new cell line of canine inflammatory mammary cancer: IPC-366.
    Caceres S; Peña L; de Andres PJ; Illera MJ; Lopez MS; Woodward WA; Reuben JM; Illera JC
    PLoS One; 2015; 10(3):e0122277. PubMed ID: 25807360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Canine cell line, IPC-366, as a good model for the study of inflammatory breast cancer.
    Caceres S; Peña L; Lacerda L; Illera MJ; de Andres PJ; Larson RA; Gao H; Debeb BG; Woodward WA; Reuben JM; Illera JC
    Vet Comp Oncol; 2017 Sep; 15(3):980-995. PubMed ID: 27146723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell adhesion molecules E-cadherin and CADM1 are differently expressed in canine inflammatory mammary cancer.
    Alonso-Diez A; Affolter VK; Sevane N; Dunner S; Valdivia G; Clemente M; De Andrés PJ; Illera JC; Pérez-Alenza MD; Peña L
    Res Vet Sci; 2022 Dec; 152():307-313. PubMed ID: 36084372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased levels of interleukins 8 and 10 as findings of canine inflammatory mammary cancer.
    de Andrés PJ; Illera JC; Cáceres S; Díez L; Pérez-Alenza MD; Peña L
    Vet Immunol Immunopathol; 2013 Apr; 152(3-4):245-51. PubMed ID: 23351639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different role of COX-2 and angiogenesis in canine inflammatory and non-inflammatory mammary cancer.
    Clemente M; Sánchez-Archidona AR; Sardón D; Díez L; Martín-Ruiz A; Caceres S; Sassi F; Dolores Pérez-Alenza M; Illera JC; Dunner S; Peña L
    Vet J; 2013 Aug; 197(2):427-32. PubMed ID: 23489848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bicalutamide Enhances Conventional Chemotherapy in In Vitro and In Vivo Assays Using Human and Canine Inflammatory Mammary Cancer Cell Lines.
    Crespo B; Illera JC; Silvan G; Lopez-Plaza P; Herrera de la Muela M; de la Puente Yague M; Diaz Del Arco C; de Andrés PJ; Illera MJ; Caceres S
    Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39063165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metastasis of canine inflammatory versus non-inflammatory mammary tumours.
    Clemente M; Pérez-Alenza MD; Peña L
    J Comp Pathol; 2010; 143(2-3):157-63. PubMed ID: 20427049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment of a new cell line of canine inflammatory mammary cancer: IMC-118.
    Gao H; Zhou H; Gao Y; He L; Li W; Xu M; Feng H; Feng X; Qiu C
    Vet Comp Oncol; 2022 Sep; 20(3):679-687. PubMed ID: 35429113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Processing and characterization of canine mixed mammary tumor using transmission electron microscopy.
    Audrey B; Alexis D; Andrea V; Julio O; Freddy PP
    Microsc Res Tech; 2017 Nov; 80(11):1229-1233. PubMed ID: 28799678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steroid Tumor Environment in Male and Female Mice Model of Canine and Human Inflammatory Breast Cancer.
    Caceres S; Peña L; Silvan G; Illera MJ; Woodward WA; Reuben JM; Illera JC
    Biomed Res Int; 2016; 2016():8909878. PubMed ID: 27195300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment and characterization of a canine xenograft model of inflammatory mammary carcinoma.
    Camacho L; Peña L; González Gil A; Cáceres S; Díez L; Illera JC
    Res Vet Sci; 2013 Dec; 95(3):1068-75. PubMed ID: 23972378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of vascular endothelial growth factor in canine inflammatory and non-inflammatory mammary carcinoma.
    Millanta F; Caneschi V; Ressel L; Citi S; Poli A
    J Comp Pathol; 2010 Jan; 142(1):36-42. PubMed ID: 19632688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary investigation of extracellular vesicles in mammary cancer of dogs and cats: Identification and characterization.
    Sammarco A; Finesso G; Cavicchioli L; Ferro S; Caicci F; Zanetti R; Sacchetto R; Zappulli V
    Vet Comp Oncol; 2018 Dec; 16(4):489-496. PubMed ID: 29851284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment of three-dimensional canine osteosarcoma cell lines showing vasculogenic mimicry and evaluation of biological properties after treatment with 17-AAG.
    Massimini M; De Maria R; Malatesta D; Romanucci M; D'Anselmo A; Della Salda L
    Vet Comp Oncol; 2019 Sep; 17(3):376-384. PubMed ID: 31006970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathways Involved in the Development of Vasculogenic Mimicry in Canine Mammary Carcinoma Cell Cultures.
    Guiraldelli GG; Prado MCM; de F Lainetti P; Leis-Filho AF; Kobayashi PE; Cury SS; Fonseca-Alves CE; Laufer-Amorim R
    J Comp Pathol; 2022 Apr; 192():50-60. PubMed ID: 35305714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profile of Steroid Receptors and Increased Aromatase Immunoexpression in Canine Inflammatory Mammary Cancer as a Potential Therapeutic Target.
    De Andrés PJ; Cáceres S; Clemente M; Pérez-Alenza MD; Illera JC; Peña L
    Reprod Domest Anim; 2016 Apr; 51(2):269-75. PubMed ID: 26899138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative pathology of canine mammary tumours.
    Nerurkar VR; Chitale AR; Jalnapurkar BV; Naik SN; Lalitha VS
    J Comp Pathol; 1989 Nov; 101(4):389-97. PubMed ID: 2558128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of transgelin blocks interleukin-8 utilization and suppresses vasculogenic mimicry in breast cancer cells.
    Aikins AR; Kim M; Raymundo B; Kim CW
    Exp Biol Med (Maywood); 2017 Mar; 242(6):573-583. PubMed ID: 28058861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.